Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): A multicentre, randomised controlled trial

Elvira O.G. Van Vliet, Tobias A.J. Nijman, Ewoud Schuit, Karst Y. Heida, Brent C. Opmeer, Marjolein Kok, Wilfried Gyselaers, Martina M. Porath, Mallory Woiski, Caroline J. Bax, Kitty W.M. Bloemenkamp, Hubertina C.J. Scheepers, Yves Jacquemyn, Erik Van Beek, Johannes J. Duvekot, Maureen T.M. Franssen, Dimitri N. Papatsonis, Joke H. Kok, Joris A.M. Van Der Post, Arie FranxBen W. Mol, Martijn A. Oudijk*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

52 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): A multicentre, randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences